Answers are grounded in this paper and cite their sources.
(1 R ,2 S )‐1‐Amino‐2‐vinylcyclopropane‐1‐carboxylic acid (vinyl‐ACCA) is the essential pharmacophoric unit in a new generation of highly potent hepatitis C virus (HCV) NS3/4A protease inhibitors. Currently, there are over a dozen drugs under development that use the special properties of this highly sterically constrained tailor‐made amino acid, underscoring the extremely high demand for the asymmetric synthesis of (1 R ,2 S )‐vinyl‐ACCA. This work presents a comprehensive overview of methods that have been developed to date for the preparation of (1 R ,2 S )‐vinyl‐ACCA and its optical isomers. The presented data are grouped in three sections based on the biocatalytic, catalytic, and stoichiometric source of chirality. Aspects of operational convenience, practicality, and scalability are critically discussed.
No takes yet. Share an insight, caveat, or question.
Sato et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: